Algert Global’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Sell |
21,919
-53,010
| -71% | -$2.83M | 0.02% | 773 |
|
|
2025
Q1 | $3.03M | Buy |
74,929
+15,195
| +25% | +$615K | 0.08% | 457 |
|
|
2024
Q4 | $1.66M | Sell |
59,734
-8,318
| -12% | -$231K | 0.04% | 667 |
|
|
2024
Q3 | $1.95M | Buy |
68,052
+5,191
| +8% | +$149K | 0.05% | 558 |
|
|
2024
Q2 | $1.48M | Sell |
62,861
-24,562
| -28% | -$576K | 0.05% | 564 |
|
|
2024
Q1 | $2.21M | Buy |
87,423
+38,873
| +80% | +$982K | 0.09% | 383 |
|
|
2023
Q4 | $1.13M | Buy |
48,550
+37,776
| +351% | +$882K | 0.05% | 587 |
|
|
2023
Q3 | $545K | Sell |
10,774
-11,790
| -52% | -$596K | 0.03% | 714 |
|
|
2023
Q2 | $1.05M | Hold |
22,564
| – | – | 0.05% | 643 |
|
|
2023
Q1 | $863K | Buy |
22,564
+8,656
| +62% | +$331K | 0.04% | 687 |
|
|
2022
Q4 | $762K | Buy |
+13,908
| New | +$762K | 0.04% | 676 |
|